Insulin-sensitizing drug for depression
Pioglitazone, available generically for treating Type 2 diabetes, improved symptoms of long-term depression in patients also suffering from insulin resistance.
Viral genetic material aids human development
Genetic residue from ancient viral infections has been repurposed to play a vital role in acquiring pluripotency, the developmental state that allows a fertilized human egg to become all the cells in the body.
Small RNAs block tumor growth
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Spyros Andreopoulos, former head of Stanford Medicine’s news and public affairs office, dies at 86
Spyros Andreopoulos advocated for transparency during his 30 years as director of Stanford Medicine’s news and public affairs office. He died Nov. 20.
Nine professors elected fellows of AAAS
Eight faculty members from the School of Medicine and one from the School of Humanities and Sciences have been elected fellows of the American Association for the Advancement of Science.
Musician-turned-scientist develops drug for inflammatory bowel disease
Finding an alternative remedy for her ulcerative colitis set a Stanford musicology student on a new and unexpected career path as a scientist and entrepreneurial drug developer.